NNG logo

NanoGroup S.A. Stock Price

WSE:NNG Community·zł84.8m Market Cap
  • 1 Narratives written by author
  • 0 Comments on narratives written by author
  • 12 Fair Values set on narratives written by author

NNG Share Price Performance

zł2.64
-0.73 (-21.58%)
zł2.64
-0.73 (-21.58%)
Price zł2.64
fis_wse

NNG Community Narratives

fis_wse·
Fair Value zł0 n/aintrinsic discount

Expect big change: Nanogroup's NanOX system will tackle global kidney shortages

0users have liked this narrative
0users have commented on this narrative
10users have followed this narrative

Trending Discussion

Updated Narratives

NNG logo

Expect big change: Nanogroup's NanOX system will tackle global kidney shortages

Fair Value: zł0 0% overvalued intrinsic discount
10 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Mediocre balance sheet with low risk.

3 Risks
0 Rewards

NanoGroup S.A. Key Details

-zł6.9k

Revenue

zł249.6k

Cost of Revenue

-zł256.5k

Gross Profit

zł6.7m

Other Expenses

-zł6.9m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
-0.22
3,716.80%
100,429.90%
0%
View Full Analysis

About NNG

Founded
2016
Employees
n/a
CEO
Przemyslaw Mazurek
WebsiteView website
nanogroup.eu

NanoGroup S.A. operates as a biotechnology company in Poland. The company develops and licenses early-stage pre-clinical and IND solutions to international biotech and pharma companies. It also manages a portfolio of companies that manages projects for the need of modern medicine in the field of oncology and transplantology. The company was incorporated in 2016 and is based in Warsaw, Poland.

Recent NNG News & Updates

Recent updates

No updates